Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) mHealth Randomized Controlled Hybrid Type I Effectiveness Implementation Trial

NCT07125235 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT07125235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07125235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) mHealth Randomized Controlled Hybrid Type I Effectiveness Implementation Trial
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Recruiting
Start date
February 9, 2026
Completion date
July 30, 2028
Enrollment
270 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

art adherence, behavioral intervention, viral suppression of hiv infection